The Harvard Drug Group recalls Memantine Hydrochloride Extended-release Capsules, 28mg, packaged in 100-count Unit Dose Cartons , Rx only, Manufactured
Recalled February 26, 2020 · FDA recall D-0844-2020 · The Harvard Drug Group
Hazard
Failed Dissolution Specifications: High out of specification result observed at stability studies. · FDA Class III
Units
246 Cartons
Sold at
U.S.A. Nationwide
Description
Failed Dissolution Specifications: High out of specification result observed at stability studies.
Product
Memantine Hydrochloride Extended-release Capsules, 28mg, packaged in 100-count Unit Dose Cartons , Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202 United States; Distributed by: Major Pharmaceuticals, 17177 N Laurel Park Dr., Suite 233, Livonia, MI 48152 USA, NDC 0904-6735-61
Manufacturer(s)
The Harvard Drug Group
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →